mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.23 |
2e-06 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-06 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |